The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength - Wikidata - wikimedia - TriplyDB

The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength

The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength

http://www.wikidata.org/entity/Q34682599

about

Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspects Ultra-short echo-time MRI detects changes in bone mineralization and water content in OVX rat bone in response to alendronate treatment.Radiodensitometric study for evaluation of bone mineral density around dental implants after zoledronic acid treatment in ovariectomized rats.Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.Effect of intraspecimen spatial variation in tissue mineral density on the apparent stiffness of trabecular bone.Variability of tissue mineral density can determine physiological creep of human vertebral cancellous bone.Glucocorticoid dose determines osteocyte cell fate.Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.β-Ecdysone Augments Peak Bone Mass in Mice of Both Sexes.Increased variability of bone tissue mineral density resulting from estrogen deficiency influences creep behavior in a rat vertebral body.Comparison of micro-CT and cone beam CT-based assessments for relative difference of grey level distribution in a human mandible.Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization Organ and tissue level properties are more sensitive to age than osteocyte lacunar characteristics in rat cortical bone.Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.Measurement of the toughness of bone: a tutorial with special reference to small animal studies.Prolonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat model Characterising bone material composition and structure in the ovariectomized (OVX) rat model of osteoporosis.Effects of orthodontic treatment on human alveolar bone density distribution.Improved Mobilization of Exogenous Mesenchymal Stem Cells to Bone for Fracture Healing and Sex Difference.Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment?Effect of osteoporosis treatment agents on the cortical bone osteocyte microenvironment in adult estrogen-deficient, osteopenic rats.

P2860

Q27025945-584A129C-4D32-4D0A-97CE-50F8BBBCCEBF Q33526115-F44AF98F-732D-4616-85DA-01A33094D319 Q33688060-5E708FC7-BE68-4778-852C-C4D513E1660C Q34149279-5FFC3E74-5342-4517-B2F6-9ACF990BD41A Q34912232-8222591A-D444-4642-8640-78C0696AEE1D Q35000270-DC58FA8B-9311-48CE-91CF-5D5109671707 Q35225093-0439CAD5-731F-460C-B67B-C27D19A365ED Q35384673-D3ACB116-84D3-4324-8884-1F2A75C94424 Q35747404-E710F015-583A-4522-A93A-FC444C9BBD79 Q35807379-7E33A4B2-42DD-4A41-960A-8B4B4D75E532 Q36269139-DB89845A-0942-4B56-9996-5F9DA0781D42 Q36886698-AB920CD3-5FAE-4B7D-83EA-C2377B2FE764 Q37003240-C53B58B0-B314-479E-BA90-421DC036A4E8 Q37051644-50A30DAC-4912-4351-A0F7-882BA2FE4DF2 Q37119856-34D8F59B-D8F8-43C4-9B7C-81076535C065 Q37223996-B457E828-6A06-4C9A-AEA6-90EBFFC00F70 Q37244297-ABFB758B-9E84-4464-9173-DF4CD4A827B7 Q41039687-6A3A7249-7F55-4119-9622-77C0C7DCBBD8 Q44387093-0F69381A-4A12-42E1-98C3-21098CC209D1 Q46898799-FF894D98-B9BA-4390-823D-E487B828C748 Q47925186-26EA333A-9871-4CE7-AB5F-A1B9D66D617E Q55384465-8F8A787E-3DC8-4716-8148-7C9F48419442

P2860

The degree of bone mineralization is maintained with single intravenous bisphosphonates in aged estrogen-deficient rats and is a strong predictor of bone strength

http://www.wikidata.org/entity/Q34682599

description

2007 nî lūn-bûn

@nan

2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

The degree of bone mineralizat ...... ong predictor of bone strength

@ast

The degree of bone mineralizat ...... ong predictor of bone strength

@en

The degree of bone mineralizat ...... ong predictor of bone strength

@nl

type

label

The degree of bone mineralizat ...... ong predictor of bone strength

@ast

The degree of bone mineralizat ...... ong predictor of bone strength

@en

The degree of bone mineralizat ...... ong predictor of bone strength

@nl

prefLabel

The degree of bone mineralizat ...... ong predictor of bone strength

@ast

The degree of bone mineralizat ...... ong predictor of bone strength

@en

The degree of bone mineralizat ...... ong predictor of bone strength

@nl

P1433

Q34682599-74B87A27-446E-4397-85A8-CDCC79A42C5D

P1476

Q34682599-EB7C55E6-E281-493B-BFC7-019E4999DC5B

P2093

Q34682599-0106523C-2F27-4172-8574-FBCD559077BF

Q34682599-1384174E-86B7-455A-8EFE-3EDBA72F2DBE

Q34682599-2712E39B-D0D4-42C4-9EEE-2DBB2C2B41A1

Q34682599-42927EC0-F2D8-47CE-8C10-7DB49857C8AB

Q34682599-4696DF69-50DD-43A0-84C0-4F7CF9C17820

Q34682599-6AFCD444-3C8A-4769-A1A8-249542036719

Q34682599-96DF5247-DBF5-4094-B012-262450487364

Q34682599-9C6F0EDB-C335-4910-88DA-913475192DF2

Q34682599-C48A0A97-DF63-4C5B-9F88-A547EC9F9FBC

P2860

Q34682599-0CF77A8B-E671-45CD-B1A1-2245F3E5892D

Q34682599-142F0B56-2662-43B8-92E7-B80F72093FC3

Q34682599-264F20BA-B776-4626-8CDD-8E7B52C0DD26

Q34682599-27E94A1E-E441-42A0-AEA0-70F4C501DFA4

Q34682599-2F656907-408B-4CD4-A3F4-8D3853B1DF5F

Q34682599-3104DDD6-D7EE-4BE4-A927-B8BB2AC46DDB

Q34682599-46E9057D-1A5A-43D4-8EB2-0D974AC7A5F3

Q34682599-4C1DF3E0-97F9-40F6-87E8-50C713F61381

Q34682599-6913218B-7A98-455F-84F8-46A57D8FB3B3

Q34682599-6F391A5F-0990-4EBB-8A09-26444A43F1F6

P304

Q34682599-851AB89F-8A8C-4FD4-B5A2-69A4E764AB8E

P31

Q34682599-4C84AAFC-4152-4D6E-BFE1-1BFC2F074446

P356

Q34682599-16058552-8BD3-4145-9946-A52CC761084A

P433

Q34682599-EBBFB18D-660F-4F34-BFDB-E5F8088D3339

P478

Q34682599-3D537896-EB2D-49AC-A1FA-E49FB39C5F98

P50

Q34682599-09DD8088-FA54-431A-AF20-6EDD9CA08BCF

P577

Q34682599-E1F441A2-8AFA-4935-B5DE-3D0BE6020019

P5875

Q34682599-E27022BE-9B53-4EF1-990C-1197FD2FE654

P698

Q34682599-9F9ED727-733F-4AAC-A62F-ABE9002F83D4

P932

Q34682599-1B8DEA8C-A22B-4679-9DD6-0763621C927F

P356

J.BONE.2007.06.021

P1433

P1476

The degree of bone mineralizat ...... ong predictor of bone strength

@en

P2093

Aaron Pham

http://www.w3.org/2001/XMLSchema#string

Cheryl Busse

http://www.w3.org/2001/XMLSchema#string

Kurt J Koester

http://www.w3.org/2001/XMLSchema#string

Mehdi Balooch

http://www.w3.org/2001/XMLSchema#string

Nancy E Lane

http://www.w3.org/2001/XMLSchema#string

Robert O Ritchie

http://www.w3.org/2001/XMLSchema#string

Solomon Chefo

http://www.w3.org/2001/XMLSchema#string

Wei Yao

http://www.w3.org/2001/XMLSchema#string

Zhiqiang Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.

Bisphosphonates: from the laboratory to the clinic and back again.

Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation.

Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice.

A biomechanical perspective on bone quality.

Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering.

The compositional and physicochemical homogeneity of male femoral cortex increases after the sixth decade.

Bone mineralization as studied by small-angle x-ray scattering.

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

P304

804-812

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BONE.2007.06.021

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6014159

http://www.w3.org/2001/XMLSchema#string

P698

17825637

http://www.w3.org/2001/XMLSchema#string

P932

3883569

http://www.w3.org/2001/XMLSchema#string